SCHEMBL17635358

SCHEMBL17635358

CCOC(=O)[C@@H](C)OP(=O)(Cl)Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.39
ALDH1A1 P00352 7/20 0.37
LMNA P02545 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KMT2A Q03164 1/20 0.36
ALOX15 P16050 3/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
SOAT1 P35610 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.33
CPB2 Q96IY4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14521931 0.81 ALDH1A1 (0.39) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL10010823 0.81 ALDH1A1 (0.39) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL12921952 0.79 CYP2D6 (0.39) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL10012925 0.78 ALDH1A1 (0.41) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL13537802 0.78 ALDH1A1 (0.36) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL10012007 0.78 TSHR (0.46) TDP1TP53ALDH1A1LMNAHSD17B10
SCHEMBL11441570 0.77 KMT2A (0.33) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL10009516 0.76 ALDH1A1 (0.40) TDP1ALDH1A1LMNAHSD17B10KMT2A
SCHEMBL19827629 0.75 TP53 (0.35) TDP1TP53
SCHEMBL6711862 0.74 ALDH1A1 (0.40) TDP1TP53ALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296778-B2 3′,5′-cyclic phosphate prodrugs for HCV infection IDENIX PHARMACEUTICALS, INC. (US) 2016-03-29 US disclosed
US-9296778-B2 3′,5′-cyclic phosphate prodrugs for HCV infection IDENIX PHARMACEUTICALS, INC. (US) 2016-03-29 US disclosed